+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anxiety Drugs Market Research Reports

From
Anxiolytics - Global Strategic Business Report - Product Thumbnail Image

Anxiolytics - Global Strategic Business Report

  • Report
  • March 2024
  • 78 Pages
  • Global
From
From
From
From
From
From
From
From
Gabapentin Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Gabapentin Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 144 Pages
  • Global
From
Global Obsessive-Compulsive Disorder Drugs Market 2024-2028 - Product Thumbnail Image

Global Obsessive-Compulsive Disorder Drugs Market 2024-2028

  • Report
  • December 2023
  • 159 Pages
  • Global
From
Nadolol (CAS 42200-33-9) Global Market Research Report 2024 - Product Thumbnail Image

Nadolol (CAS 42200-33-9) Global Market Research Report 2024

  • Report
  • March 2024
  • 50 Pages
  • Global
From
Meprobamate (CAS 57-53-4) Global Market Research Report 2024 - Product Thumbnail Image

Meprobamate (CAS 57-53-4) Global Market Research Report 2024

  • Report
  • March 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Anxiety Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat anxiety disorders. Anxiety drugs are typically prescribed to treat a variety of conditions, including generalized anxiety disorder, panic disorder, social anxiety disorder, and post-traumatic stress disorder. Commonly prescribed anxiety drugs include benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), and tricyclic antidepressants. Anxiety drugs are typically prescribed by a doctor or mental health professional. The drugs are usually taken orally, although some may be administered intravenously or intramuscularly. The dosage and duration of treatment vary depending on the individual's condition and response to the drug. Some of the major companies in the Anxiety Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca, and Johnson & Johnson. These companies produce a variety of anxiety drugs, including benzodiazepines, SSRIs, and tricyclic antidepressants. Show Less Read more